afatinib
Showing 1 - 25 of 96
Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)
Not yet recruiting
- Stomach Neoplasm
- Trastuzumab deruxtecan
- Afatinib
- (no location specified)
Oct 16, 2023
Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)
Completed
- Gastric Cancer
- Gastroesophageal Junction Cancer
- afatinib
- paclitaxel
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023
Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)
Recruiting
- Esophagus Squamous Cell Carcinoma
- Palbociclib
- Afatinib
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023
Real-world Data of Afatinib Treatment in First-line Setting and
Active, not recruiting
- Non-squamous, Non-Small Cell Lung Cancer
- afatinib
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023
Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)
Recruiting
- Advanced Esophageal Squamous Cell Carcinoma
- Afatinib
- Irinotecan
-
Beijing, China
- +2 more
Apr 6, 2023
Solid Tumors Trial (afatinib)
No longer available
- Solid Tumors
- afatinib
- (no location specified)
Nov 7, 2022
Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)
Recruiting
- Squamous Cell Cancers of the Head and Neck
- cetuximab
- afatinib
-
New Haven, ConnecticutYale Cancer Center
Jan 10, 2023
Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Nab-paclitaxel
- +3 more
- (no location specified)
Aug 23, 2022
Observational Study of Afatinib 30 mg Daily
Not yet recruiting
- Non-Small Cell Lung Cancer
- Epidermal Growth Factor Receptor Mutation
- Afatinib
-
Singapore, SingaporeNationa University Hospital
Apr 4, 2022
Observes Afatinib as First-line Treatment and Sequential Therapy
Active, not recruiting
- Non-squamous, Non-Small Cell Lung Cancer
- Afatinib
-
Beijing, China
- +9 more
Jan 9, 2023
Brain Cancer Trial in Santa Monica (Afatinib)
Completed
- Brain Cancer
- Afatinib
-
Santa Monica, CaliforniaJohn Wayne Cancer Institute
Mar 8, 2022
Lung Adenocarcinoma Stage III, EGFR Gene Mutation Trial in Shang'ai (Afatinib)
Recruiting
- Lung Adenocarcinoma Stage III
- EGFR Gene Mutation
- Afatinib
-
Shang'ai, Shanghai, ChinaShanghai Pulmonary Hospital
Mar 27, 2022
Solid Tumors Trial in Toronto (Afatinib)
Active, not recruiting
- Solid Tumors
- Afatinib
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 12, 2022
Non-Small Cell Lung Carcinoma Trial in Duarte, Stanford, Nashville (drug, biological, other)
Terminated
- Non-Small Cell Lung Carcinoma
- Afatinib
- +2 more
-
Duarte, California
- +2 more
Apr 6, 2022
PFS Trial in Qingdao (afatinib)
Recruiting
- PFS
- afatinib
-
Qingdao, Shandong, China
- +1 more
Feb 23, 2022
Afatinib Following Immunotherapy in Treatment of Metastatic,
Completed
- Non-squamous, Non-Small Cell Lung Cancer
- Afatinib
- other systemic therapy
-
Dublin, OhioCardinal Health
Jan 18, 2022
NSCLC Trial in United Kingdom (Afatinib)
Active, not recruiting
- Non-small Cell Lung Cancer
- Afatinib
-
Aberdeen, United Kingdom
- +6 more
Feb 22, 2022
Esophageal Squamous Carcinoma Trial in China (JMT101, Afatinib)
Recruiting
- Esophageal Squamous Carcinoma
- JMT101
- Afatinib
-
Beijing, Beijing, China
- +4 more
Dec 18, 2021
Non Small Cell Lung Cancer Trial in France (Afatinib, Cetuximab)
Completed
- Non Small Cell Lung Cancer
- Afatinib
- Cetuximab
-
Aix-en-Provence, France
- +32 more
Aug 9, 2022
NSCLC Trial in Amsterdam, Groningen, Maastricht (Afatinib, Cetuximab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Afatinib
- Cetuximab
-
Amsterdam, North-Holland, Netherlands
- +3 more
Oct 19, 2021
Lung Tumors, EGFR Gene Mutation Trial in Hwasun (Afatinib)
Completed
- Lung Neoplasms
- EGFR Gene Mutation
- Afatinib
-
Hwasun, Jeonnam, Korea, Republic ofChonnam National University Hwasun Hospital
Aug 1, 2021
Esophageal Squamous Cell Carcinoma Trial in Beijing (Afatinib, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Afatinib
- Toripalimab
-
Beijing, Beijing, ChinaPeking University Cancer Hospital and Institute
Jul 11, 2021
Cancer Medicines in Metastatic Non-small Cell Lung Cancer in
Not yet recruiting
- Non-Small Cell Lung Cancer
- lorlatinib
- +17 more
-
Oslo, NorwayPfizer Norway
Apr 17, 2023
Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)
Not yet recruiting
- Glioblastoma
- +2 more
- Afatinib
- +4 more
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Jun 24, 2022